4[1]Tavani A,La Vecchia C.Epidemiology of renal-cell carcinoma[J].J Nephrol,1997,10(2):93-106.
5[10]Osband ME,Ross S.Problems in the investigational study and clinical use of cancer immunotherapy[J].Immunol Today,1990,11(6):193-195.
6Papac R J, Keohane MF. Hormonal therapy for metastatic renal cell carci- noma combined androgen and provera followed by high dose tamoxifen [J]. Eur J Cancer,1993,29A:997 -999.
7Tavani A, La-Vecchia C. Epidemiology of renalcell carcinoma [ J ]. J Nephrol,1997,10(2) :93 - 102.
8Lummen G, Goepel M, Mollhoff S, et al. Phase II study of interferon-gam- ma versus interleukin-2 and interferon-alpha 2b in metastatic renal cell carcinoma[ J]. J Urol, 1996,155:455 -458.
9Atzpodien J, Kirclner H. IL-2 in combination with INF-alpha and 5-FU versus tamoxifen in metastatic renal cell carcinoma longterm results of controlled randmized clinical trail [ J]. Br J Cancer,2001,85 : 1130 - 1136.
